Xu J Y, Yang J, Li L Z
Hubei Academy of Traditional Chinese Medicine and Pharmacy, Wuhan.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1992 Mar;12(3):161-4, 134.
A new component of antitumor action TG has been isolated from the ethyl acetate extract of Tripterygium wilfordii (besides Triptolide, Tripdiolide and Triptonide). TG was shown in this study to have obvious antitumor effects. The average life span of H22, S180, EAC and breast carcinoma-bearing mice treated with TG ip x 2 days were 100% more than those of the control mice (P less than 0.01) TG was able to inhibit tumor growth of S37-bearing mice at the dose of 150 mg/kg per day, ig x 3, its inhibitory rate was 42% (P less than 0.01). TG could also inhibit squamous epithelial lung carcinoma induced by 3-methylcholanthrene. The inhibitory rate was 65.13% (P less than 0.05). TG had remarkable killing effect on human HL60 and Daudi cells and two direction effects on function M phi of mouse abdominal cavity in vitro.
从雷公藤乙酸乙酯提取物中分离出了一种新的抗肿瘤作用成分TG(除了雷公藤甲素、雷公藤乙素和雷公藤内酯醇)。本研究表明TG具有明显的抗肿瘤作用。经TG腹腔注射×2天治疗的H22、S180、EAC荷瘤小鼠及乳腺癌荷瘤小鼠的平均寿命比对照小鼠长100%(P<0.01)。TG以每天150mg/kg的剂量灌胃×3天,能够抑制S37荷瘤小鼠的肿瘤生长,其抑制率为42%(P<0.01)。TG还能抑制3-甲基胆蒽诱导的肺鳞状上皮癌。抑制率为65.13%(P<0.05)。TG在体外对人HL60和Daudi细胞具有显著杀伤作用,对小鼠腹腔巨噬细胞功能有双向作用。